Removal of TREX1 activity enhances CRISPR–Cas9-mediated homologous recombination
CRISPR-Cas9-mediated homology-directed repair (HDR) can introduce desired mutations at targeted genomic sites, but achieving high efficiencies is a major hurdle in many cell types, including cells deficient in DNA repair activity. In this study, we used genome-wide screening in Fanconi anemia patient lymphoblastic cell lines to uncover suppressors of CRISPR-Cas9-mediated HDR. We found that a single exonuclease, TREX1, reduces HDR efficiency when the repair template is a single-stranded or linearized double-stranded DNA. TREX1 expression serves as a biomarker for CRISPR-Cas9-mediated HDR in that the high TREX1 expression present in many different cell types (such as U2OS, Jurkat, MDA-MB-231 and primary T cells as well as hematopoietic stem and progenitor cells) predicts poor HDR. Here we demonstrate rescue of HDR efficiency (ranging from two-fold to eight-fold improvement) either by TREX1 knockout or by the use of single-stranded DNA templates chemically protected from TREX1 activity. Our data explain why some cell types are easier to edit than others and indicate routes for increasing CRISPR-Cas9-mediated HDR in TREX1-expressing contexts.
Authors
- Mehmet E. Karasu (ORCID: https://orcid.org/0000-0002-1918-9152)
- Grégoire Cullot (ORCID: https://orcid.org/0000-0003-3925-705X)
- Eléonore Toufektchan (ORCID: https://orcid.org/0000-0002-8593-1909)
- Yanyang Chen (ORCID: https://orcid.org/0000-0003-4665-9671)
- Jacob E. Corn (ORCID: https://orcid.org/0000-0002-7798-5309)
- John Maciejowski (ORCID: https://orcid.org/0000-0001-8134-9308)
- Alessandra Albertelli
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- ETH Zurich (CH)
Publication Details
- Journal
- Nature Biotechnology
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1038/s41587-024-02356-3
- Citations
- 21
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 4.91
Funders
- National Science Foundation
- European Commission
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Eidgenössische Technische Hochschule Zürich
- NOMIS Stiftung
- Functional Genomics Center Zurich
- National Cancer Institute